Buffalo, NYNCT05893940Now EnrollingIRB Ready

Hematopoietic and Lymphoid System Neoplasm Clinical Trial in Buffalo, NY

Access cutting-edge hematopoietic and lymphoid system neoplasm treatment through this clinical trial at a research site in Buffalo. Study-provided care at no cost to qualified participants.

Sponsored by Roswell Park Cancer Institute

Quick Self-Assessment

See if you qualify for this Buffalo location

Preparing your pre-screening questions…

Expert Care in Buffalo

Access hematopoietic and lymphoid system neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hematopoietic and lymphoid system neoplasm treatment provided free

Apply for This Buffalo Location

Check if you qualify for this hematopoietic and lymphoid system neoplasm clinical trial in Buffalo, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Buffalo

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Buffalo site if eligible
  4. 4Begin participation

About This Hematopoietic and Lymphoid System Neoplasm Study in Buffalo

This clinical trial tests the effect of low-intensity mechanical stimulation (LIMS) vibration therapy in patients with hematologic malignancies. Patients with hematologic malignancies often undergo a blood and/or bone marrow transplant (hematopoietic cell transplantation \[HCT\]) or cellular therapy. The LIMS board delivers vibrations through the bones that may stimulate bone growth and may also increase muscle activity and strength and may also increase T-cell activation in patients planning to undergo cellular therapy. LIMS vibration therapy may stop or reverse BMD loss and/or improve the development of T-cells in the body in patients with hematologic malignancies who are undergoing or may plan to undergo HCT or cellular therapies.

Sponsor: Roswell Park Cancer Institute

Who Can Participate

Inclusion Criteria

COHORT I: Meet eligibility criteria for first autologous or allogeneic HCT (patients with preexisting osteoporosis are eligible)
COHORT I: Scheduled to undergo an autologous or allogeneic HCT
COHORT 1: \>= 18 years of age
COHORT 1: Patient must understand the investigational nature of this study and sign an institutional review board approved written informed consent form prior to receiving any study related procedure \- COHORT II: ≥ 18 years of age
COHORT II: Diagnosis of non-Hodgkin lymphoma (specifically diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia; patients with preexisting osteoporosis are eligible)
COHORT II: Patient must understand the investigational nature of this study and sign an Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria

Any prior allogeneic HCT
Any prior autologous HCT for those patients who have a planned auto HCT
Pre-transplant weight \>= 275 lbs. (max weight for the board)
Body mass index (BMI) \< 18 kg/m\^2
Recipient of cord blood transplant
Multiple myeloma or amyloidosis diagnosis
History of a central nervous system (CNS) hemorrhage \< 60 days
History of any aneurysm (cerebral, aortic, etc.)
A recent pulmonary embolism or deep vein thrombosis
A cardiac pacemaker
Prior history of non-traumatic (spontaneous) fracture
Total joint replacement (any joint)
History of kidney stones or gall stones within the last 2 years unless a cholecystectomy was performed
Any prosthetic lower extremity or limb
Pregnant or nursing female patients
Unwilling or unable to follow protocol requirements
Any condition which in the Investigator's opinion deems the patient an unsuitable candidate to receive study intervention COHORTII:
Planned CAR T-cell therapy within the next 2 months
Prior CAR T-cell therapy
Active treatment within the last 60 days
Pre-transplant weight ≥ 275 lbs. (max weight for the board)
BMI \< 18 kg/m\^2
History of a CNS hemorrhage \< 60 days
History of any aneurysm (cerebral, aortic, etc.)
A recent pulmonary embolism or deep vein thrombosis
A cardiac pacemaker
Recent history (\< 60 days) of non-traumatic (spontaneous) fracture
Recent surgery (\< 60 days)
Pregnant or nursing female patients
Unwilling or unable to follow protocol requirements
Any condition which in the investigator's opinion deems the patient an unsuitable candidate to receive study intervention

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Buffalo?

Yes, this clinical trial (NCT05893940) has an active research site in Buffalo, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hematopoietic and Lymphoid System Neoplasm Treatment Options in Buffalo, NY

If you're searching for hematopoietic and lymphoid system neoplasm treatment options in Buffalo, NY, this clinical trial (NCT05893940) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Buffalo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hematopoietic and lymphoid system neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hematopoietic and lymphoid system neoplasm clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Buffalo, NY

See all essential tremor clinical trials recruiting in Buffalo — not just this study.

Browse Essential Tremor Trials in Buffalo

Ready to Join in Buffalo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Buffalo, NY